blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2041123

EP2041123 - FUSED CYCLIC COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.12.2012
Database last updated on 13.07.2024
Most recent event   Tooltip22.03.2013Correction of patent specificationpublished on 24.04.2013  [2013/17]
Applicant(s)For all designated states
Takeda Pharmaceutical Company Limited
1-1, Doshomachi 4-chome Chuo-ku Osaka-shi
Osaka 541-0045 / JP
[2009/14]
Inventor(s)01 / YASUMA, Tsuneo
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
17-85, Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi, Osaka 532-8686 / JP
02 / NEGORO, Nobuyuki
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
17-85, Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi, Osaka 532-8686 / JP
03 / YAMASHITA, Masayuki
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
17-85, Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi, Osaka 532-8686 / JP
04 / ITOU, Masahiro
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
17-85, Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi, Osaka 532-8686 / JP
 [2012/05]
Former [2009/14]01 / YASUMA, Tsuneo
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED, 17-85, Jusohonmachi 2-chome, Yodogawa-ku
Osaka-shi, Osaka 532-8686 / JP
02 / NEGORO, Nobuyuki
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED, 17-85, Jusohonmachi 2-chome, Yodogawa-ku
Osaka-shi, Osaka 532-8686 / JP
03 / YAMASHITA, Masayuki
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED, 17-85, Jusohonmachi 2-chome, Yodogawa-ku
Osaka-shi, Osaka 532-8686 / JP
04 / ITOU, Masahiro
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED, 17-85, Jusohonmachi 2-chome, Yodogawa-ku
Osaka-shi, Osaka 532-8686 / JP
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[N/P]
Former [2012/05]von Kreisler Selting Werner
Deichmannhaus am Dom Bahnhofsvorplatz 1
50667 Köln / DE
Former [2010/15]von Kreisler Selting Werner
Deichmannhaus am Dom Bahnhofsvorplatz 1
50667 Köln / DE
Former [2009/14]Weber, Thomas
Patentanwälte von Kreisler Selting Werner Deichmannhaus am Dom Bahnhofsvorplatz 1
50667 Köln / DE
Application number, filing date07767983.526.06.2007
[2009/14]
WO2007JP63208
Priority number, dateJP2006017709927.06.2006         Original published format: JP 2006177099
[2009/14]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008001931
Date:03.01.2008
Language:EN
[2008/01]
Type: A2 Application without search report 
No.:EP2041123
Date:01.04.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 03.01.2008 takes the place of the publication of the European patent application.
[2009/14]
Type: B1 Patent specification 
No.:EP2041123
Date:01.02.2012
Language:EN
[2012/05]
Type: B9 Corrected patent specification 
No.:EP2041123
Date:02.01.2013
[2013/01]
Type: B9 Corrected patent specification 
No.:EP2041123
Date:24.04.2013
[2013/17]
Search report(s)International search report - published on:EP11.09.2009
ClassificationIPC:C07D409/12, A61K31/192, A61P3/10
[2009/14]
CPC:
C07D409/12 (EP,KR,US); A61K31/192 (KR); A61P1/04 (EP);
A61P1/14 (EP); A61P13/12 (EP); A61P15/00 (EP);
A61P17/00 (EP); A61P19/02 (EP); A61P19/08 (EP);
A61P25/00 (EP); A61P25/18 (EP); A61P25/24 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P3/00 (EP); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P31/10 (EP); A61P35/00 (EP);
A61P37/02 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P5/50 (EP); A61P7/02 (EP); A61P7/10 (EP);
A61P9/10 (EP); A61P9/12 (EP); C07D307/80 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/14]
Extension statesAL22.12.2008
BA22.12.2008
HR22.12.2008
MK22.12.2008
RS22.12.2008
TitleGerman:KONDENSIERTE CYCLISCHE VERBINDUNGEN[2009/14]
English:FUSED CYCLIC COMPOUNDS[2009/14]
French:COMPOSÉS CYCLIQUES CONDENSÉS[2009/14]
Entry into regional phase22.12.2008National basic fee paid 
22.12.2008Designation fee(s) paid 
22.12.2008Examination fee paid 
Examination procedure22.12.2008Amendment by applicant (claims and/or description)
22.12.2008Examination requested  [2009/14]
22.12.2009Despatch of a communication from the examining division (Time limit: M04)
20.04.2010Reply to a communication from the examining division
29.03.2011Communication of intention to grant the patent
04.08.2011Fee for grant paid
04.08.2011Fee for publishing/printing paid
Divisional application(s)EP10172951.5  / EP2248812
EP11194016.9  / EP2431367
EP13190005.2  / EP2743268
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  22.12.2009
Opposition(s)05.11.2012No opposition filed within time limit [2013/02]
Fees paidRenewal fee
25.06.2009Renewal fee patent year 03
31.03.2010Renewal fee patent year 04
29.06.2011Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  Tooltipdeleted
[2012/40]
Former [2012/39]LV01.02.2012
Cited inInternational search[Y]WO2005063729  (TAKEDA PHARMACEUTICAL [JP], et al) [Y] 1-17 * examples 78,99,100,113,114 *;
 [A]EP1559422  (TAKEDA PHARMACEUTICAL [JP]) [A] 1-17 * the whole document *;
 [Y]WO2005087710  (TAKEDA PHARMACEUTICAL [JP], et al) [Y] 1-18 * abstract *;
 [DY]EP1630152  (TAKEDA PHARMACEUTICAL [JP]) [DY] 1-18 * examples 50-62,69-72 * * paragraphs [0014] , [0235] , [0334] * [Y] 19;
 [PA]EP1698624  (TAKEDA PHARMACEUTICAL [JP]) [PA] 1-17 * the whole document *;
 [PY]EP1726580  (TAKEDA PHARMACEUTICAL [JP]) [PY] 1-18 * examples 250-253 *;
 [PA]EP1731505  (TAKEDA PHARMACEUTICAL [JP]) [PA] 1-17 * the whole document *;
 [A]  - TRALDI, O.; ET AL., ORGANIC MASS SPECTROMETRY, (1985), vol. 20, no. 1, pages 53 - 57, XP002460665 [A] 18,19 * page 54; examples 1-4,d,and,e *

DOI:   http://dx.doi.org/10.1002/oms.1210200112
 [Y]  - CUI X, BURGESS K, "Catalytic homogeneous asymmetric hydrogenations of largely unfunctionalized alkenes", CHEMICAL REVIEWS, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC., (2005), vol. 105, no. 9, pages 3272 - 3296, XP002535915 [Y] 19 * the whole document * * in particular section 6.2 *

DOI:   http://dx.doi.org/10.1021/CR0500131
 [Y]  - BARBARO P ET AL, "Progress in stereoselective catalysis by metal complexes with chiral ferrocenyl phosphines", COORDINATION CHEMISTRY REVIEWS, ELSEVIER SCIENCE, AMSTERDAM, NL, (20041201), vol. 248, no. 21-24, ISSN 0010-8545, pages 2131 - 2150, XP004917423 [Y] 19 * section 2.1.1, in particular equation (10) *

DOI:   http://dx.doi.org/10.1016/j.ccr.2004.03.022
 [Y]  - BURK M J, "Modular phospholane ligands in asymmetric catalysis", ACCOUNTS OF CHEMICAL RESEARCH., ACS, WASHINGTON, DC., (2000), vol. 33, no. 6, pages 363 - 372, XP002535916 [Y] 19 * the whole document * * in particular figure 6 *

DOI:   http://dx.doi.org/10.1021/AR990085C
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.